Recombinant Human GJA5 Protein ，His

GJA5, or Gap Junction Protein Alpha 5, is a member of the connexin family that plays a critical role in cell communication by forming gap junctions, which allow for the passage of ions and small molecules between adjacent cells. Research on GJA5 has gained attention due to its significance in cardiovascular development and function, particularly in the context of heart rhythm regulation and the pathophysiology of various cardiac diseases, including atrial fibrillation and congenital heart defects. Mutations in the GJA5 gene have been linked to arrhythmogenic disorders, emphasizing the importance of understanding its molecular mechanisms and interactions. Recombinant GJA5 protein studies enable researchers to investigate the structure-function relationship of connexins, identify potential drug targets, and explore therapeutic strategies for cardiac conditions. These studies utilize techniques such as protein expression systems and electrophysiological assays to assess the functional properties of GJA5, contributing to a deeper understanding of its role in cellular communication and its implications for heart health. As such, GJA5 recombinant protein research is pivotal in unraveling the complexities of cardiac signaling and developing innovative approaches to counteract heart-related diseases.